Equity Compensation · 15 min read

Diversifying Concentrated Stock After an IPO: Your Options

The Financial Sciences Company Published Sep 26, 2026

The short answer

Start with your company’s insider trading policy. NVIDIA, Apple, Alphabet and Meta prohibit hedging for covered employees, most also restrict pledging, and Meta names exchange funds, so collars, prepaid forwards and pooled funds are often unavailable while you work there, and no hedge is permitted on shares still under a lockup. What remains for most holders is staged selling, often through a 10b5-1 plan, gifts of long-term lots to charity, and direct indexing around the position. Each strategy carries a cost, a risk and an eligibility gate, set out below.

Most articles on concentrated stock open with a menu of strategies. The menu is the wrong place to start, because for a current employee of many public companies half of it is prohibited by the insider trading policy, and for anyone still under a lockup all of it is. This article starts with the policy, then walks through each strategy with the same four lines: how it works, what it costs, what can go wrong, and who is eligible. A worked example compares selling at once with selling over several tax years. Figures are 2026 federal figures; confirm your own with a CPA or tax counsel.

Why check the insider trading policy first?

Because it may already have made several of the decisions for you. Since 2024, companies file their insider trading policies as Exhibit 19 to the Form 10-K, so the rules are public and citable. Four large employers show the pattern:

Hedging, pledging and planned-selling rules from insider trading policies filed as Exhibit 19 to each company’s Form 10-K. Company names identify the filings only; no affiliation is implied. Read your own policy; it may have changed.
Company	Hedging (collars, forwards, swaps, options)	Pledging and margin	Planned selling	Who is covered
NVIDIA	Prohibited, naming equity swaps, prepaid forward sale contracts, collars and straddles; short sales prohibited	Prohibited	10b5-1 plans permitted; trades under a plan may execute in a closed window	Employees, board members, contractors and consultants, at all times
Apple	Short sales, hedging and derivative transactions prohibited at all times	Prohibited for directors and executive officers	10b5-1 plans with a cooling-off period: 30 days or the day after earnings for most employees; up to 120 days for Section 16 officers	All covered personnel
Alphabet	Short sales, hedging and other derivative transactions prohibited	Pledging and margin accounts prohibited	Trading through the company’s Employee Trading Plan program or an approved 10b5-1 plan	Employees, officers, directors, household members and controlled entities
Meta	Prohibited, naming puts, calls, collars, forward sale contracts, equity swaps and exchange funds	Prohibited except as approved by a board committee	10b5-1 plans required for designated persons	Directors, officers, employees, household members, consultants and contractors

Sources: NVIDIA (NVIDIA insider trading policy, Exhibit 19.1 to the fiscal 2026 Form 10-K); Apple (Apple insider trading policy, Exhibit 19.1 to the fiscal 2024 Form 10-K); Alphabet (Alphabet insider trading policy, Exhibit 19.1 to the 2024 Form 10-K); Meta (Meta insider trading policy, Exhibit 19.1 to the 2024 Form 10-K). Three details matter. The bans apply at all times, not just in closed windows. They usually extend to spouses, household members and accounts you control. And Meta names exchange funds, so a strategy often presented as the answer for employees can itself be a violation. Lockups add a second gate: the SpaceX lock-up agreement bars any hedging or other transaction designed to transfer the economic consequences of owning locked shares, so no collar or forward is possible on those shares before release (SpaceX Form 424(b)(4) prospectus, June 11, 2026, Underwriting—Lock-up Agreements).

For a current employee under policies like these, the working toolkit is staged selling, charitable gifts and direct indexing around the position. Exchange funds, collars and prepaid forwards enter the picture after departure, or at employers whose policies permit them, and only for holders who meet the eligibility tests below.

Staged sales, including through a 10b5-1 plan

How it works: sell a fixed fraction of the position at set intervals, at set prices, or as lots cross the one-year mark, inside open windows. A Rule 10b5-1 plan writes the schedule down in advance so trades execute even in closed windows. Employees who are not directors or officers wait 30 days after adoption before the plan can trade; directors and officers wait the later of 90 days or two business days after the next quarterly results, capped at 120 days (SEC Rule 10b5-1, 17 CFR §240.10b5-1(c)(1)(ii)). Plans must be adopted in good faith, and only one single-trade plan may be adopted in any 12 months (SEC Release 33-11138, December 2022).
Costs: tax on each sale, at long-term rates for lots held more than a year: in 2026, 0% up to $98,900 of taxable income for joint filers, 15% up to $613,700, and 20% above ($49,450 and $545,500 for single filers) (Rev. Proc. 2025-32, section 3.03), plus the 3.8% net investment income tax above $250,000 of modified adjusted gross income for joint filers, $200,000 single (26 U.S.C. §1411). A plan also costs flexibility; once adopted it should be left alone.
Risks: the stock may rise after you sell, which is regret rather than loss, but real. A schedule that ignores blackout windows or the cooling-off period can leave a release date unsellable. Pre-clearance may apply.
Who is eligible: anyone with released shares and an open window. It is the one strategy every policy in the table permits.

Selling at once vs. over several years: an illustration

The household is hypothetical and the numbers are round. A single filer with $200,000 of salary holds $2,000,000 of employer stock with a $400,000 basis, all long-term, so the built-in gain is $1,600,000. To keep the arithmetic visible, deductions and state tax are ignored, the share price is held flat, and 2026 federal thresholds apply to every year: 15% on long-term gains until taxable income reaches $545,500, 20% above (Rev. Proc. 2025-32, section 3.03), and 3.8% net investment income tax on the whole gain because income exceeds $200,000 (26 U.S.C. §1411).

Hypothetical, single filer, 2026 federal thresholds (Rev. Proc. 2025-32; 26 U.S.C. §1411) applied to all years, flat share price, no deductions or state tax. Illustrative only.
Item	Sell all in 2026	Sell one quarter a year, 2026 to 2029
Long-term gain recognized	$1,600,000 in one year	$400,000 in each of four years
Gain taxed at 15% (income from $200,000 to $545,500)	$345,500 once: $51,825	$345,500 each year: $51,825 × 4 = $207,300
Gain taxed at 20%	$1,254,500: $250,900	$54,500 each year: $10,900 × 4 = $43,600
Net investment income tax at 3.8%	$60,800	$15,200 × 4 = $60,800
Total federal tax on the gain	$363,525	$311,700
Difference	$51,825, or about 3.2% of the gain, from running $345,500 of gain through the 15% band three more times

Staging buys $51,825 of federal tax. It costs three more years with most of the money in one stock: after the first sale, $1,500,000 remains in the position, and a decline of about 3.5% in that remainder, roughly $52,500, would erase the saving. Whether the trade is worth it depends on the second number, not the first. Two notes: a state that taxes gains as ordinary income changes the arithmetic, a state with no income tax does not; and a year of unusually low other income, such as the year after leaving a job, can open the 0% band for part of a sale.

Exchange funds (section 721)

How it works: you contribute shares to a partnership alongside other investors contributing other stocks and receive an interest in the diversified pool. No gain is recognized on the contribution (26 U.S.C. §721(a), (b)), provided the partnership is not an investment company, which the regulations define as one whose readily marketable stocks and securities exceed 80% of its assets (Treas. Reg. §1.351-1(c)(1)(ii)). That is why exchange funds hold about 20% in qualifying non-security assets, typically real estate. Your basis carries over; the tax is deferred, not removed.
Costs: management fees for the life of the fund and, in many funds, borrowing costs for the real-estate sleeve. Withdrawing diversified shares within seven years triggers the built-in gain, so the practical hold is seven years (26 U.S.C. §704(c)(1)(B)) (26 U.S.C. §737). The fund holds whatever other contributors brought, which in recent funds has skewed heavily toward technology stocks (Kitces.com, April 2026, secondary source).
Risks: seven years of illiquidity; sector concentration inside the fund; a real-estate sleeve that can cost more in interest than it earns; and a deferred gain that is still there when you eventually sell. A policy that bans exchange funds, as Meta’s does, ends the analysis for covered employees.
Who is eligible: private offerings, generally limited to accredited investors (net worth over $1,000,000 excluding the primary residence, or income over $200,000, $300,000 with a spouse, in each of the last two years) (Regulation D, Rule 501(a), 17 CFR §230.501) or, for many funds, qualified purchasers with at least $5,000,000 in investments (Investment Company Act §2(a)(51), 15 U.S.C. §80a-2(a)(51)). Funds cap how much of one stock they accept, and a recently listed stock may be accepted in limited size or not at all. Eligibility also runs through the employer: Meta’s policy lists exchange funds in its hedging ban, next to puts, calls, collars, forward sale contracts and equity swaps, so for its covered employees the fund is not available at all, whatever their net worth (Meta insider trading policy, Exhibit 19.1 to the 2024 Form 10-K).

Prepaid variable forwards

How it works: a dealer pays you a large part of the position’s value today, and you agree to deliver a variable number of shares, or the cash equivalent, on a future date, keeping dividends and some upside to a cap with protection below a floor. Under Rev. Rul. 2003-7 this is neither a current sale nor a constructive sale if you pledge no more than the maximum shares deliverable, keep an unrestricted right to substitute cash or other shares, are not economically compelled to deliver the pledged shares, and the dealer cannot dispose of them (Rev. Rul. 2003-7).
Costs: the discount on the upfront payment, the dealer’s spread on the embedded options, and the upside above the cap. The gain is recognized at settlement.
Risks: if the terms drift from the ruling’s facts, for example by lending the pledged shares to the dealer, the transaction can be treated as a sale when entered; section 1259 treats a forward contract to deliver the same or substantially identical property as a constructive sale (26 U.S.C. §1259). Counterparty risk runs to the dealer, and straddle rules can suspend losses and holding periods.
Who is eligible: holders with positions large enough for a dealer program, outside any lockup, at companies whose policies permit hedging and pledging. The four policies above prohibit both, and NVIDIA’s names prepaid forwards.

Collars

How it works: buy a put below the current price and sell a call above it, often for little or no net premium. The position is protected below the put strike and capped above the call strike for the life of the options.
Costs: the net premium, if any; the forgone gain above the call; and the tax treatment of the options themselves, which sit under the straddle rules.
Risks: a collar that is too tight can be treated as a constructive sale. Section 1259 lists short sales, offsetting notional principal contracts and forward contracts, and authorizes Treasury to add transactions with substantially similar effect; the statute gives no bright-line band, so a narrow collar is a judgment call with counsel (26 U.S.C. §1259). A collar closed within 30 days after year-end, with the stock held unhedged for the following 60 days, falls within a statutory exception (26 U.S.C. §1259).
Who is eligible: holders with options approval at a brokerage, on released shares, at companies whose policies permit derivative transactions. All four policies above prohibit them for covered persons.

Charitable tools: donor-advised funds and charitable remainder trusts

How it works: a gift of publicly traded stock held more than a year to a donor-advised fund or other public charity is deductible at fair market value, and the built-in gain is never taxed. The deduction is limited to 30% of adjusted gross income with a five-year carryover, and stock held a year or less is deductible only at basis (IRS Publication 526) (26 U.S.C. §170(b)(1)(C), (I)). From 2026, charitable deductions count only to the extent total gifts exceed 0.5% of adjusted gross income (26 U.S.C. §170(b)(1)(C), (I)). A charitable remainder trust goes a step further: the trust sells the stock free of tax, pays you or your family a fixed annuity or a fixed 5% to 50% of trust assets for a term or for life, and the remainder, worth at least 10% of the contribution at the outset, passes to charity (26 U.S.C. §664(c), (d)).
Costs: the gift itself; the money is no longer yours. A remainder trust adds drafting, trustee and annual administration costs, and its payouts are taxed to you under tiers that generally deliver ordinary income first.
Risks: both are irrevocable. A remainder trust’s payments depend on its investments after the sale. Recently vested RSU lots are short-term and give only a basis deduction, so lot selection matters. Gifts of locked shares require the recipient to sign a lockup.
Who is eligible: anyone with appreciated long-term shares and charitable intent; a remainder trust makes sense only at a size that justifies its administration. No policy in the table restricts gifts, though pre-clearance may apply.

Direct indexing around the position

How it works: the rest of the portfolio is held as individual stocks tracking an index, with the employer’s stock and often its sector excluded so the overall exposure is not doubled. Individual holdings that fall are sold and replaced with similar ones, and the realized losses offset gains from the staged sales of the concentrated position. Our direct indexing page describes how we run it.
Costs: a management fee on the indexed sleeve and some tracking difference from the index, especially when a large sector is excluded.
Risks: harvested losses tend to run down after the first few years as the sleeve’s basis rises, so the offset is strongest early; wash-sale rules limit what can be repurchased; and the strategy does not reduce the concentrated position by itself. It makes the staged sales cheaper; it does not replace them.
Who is eligible: any taxable investor with enough outside assets to fund the sleeve. No policy conflict, since the employer’s stock is excluded rather than traded.

The strategies side by side

Summary of the strategies above. “Policy conflict” refers to the four Exhibit 19 policies in the first table; check your own.
Strategy	Tax on the gain	Reduces the position?	Eligibility gate	Policy conflict for covered employees
Staged sales / 10b5-1	Paid as you sell	Yes	Released shares, open window or plan	None; plans expressly permitted
Exchange fund	Deferred; basis carries over; 7-year hold	Yes, into a pooled portfolio	Accredited investor or qualified purchaser	Meta names exchange funds; others ban hedging broadly
Prepaid variable forward	Deferred to settlement	Economically, within a band	Dealer minimums; released shares	Yes: hedging and pledging bans
Collar	None until sale, if not a constructive sale	No; limits the range	Options approval; released shares	Yes: derivative and hedging bans
Donor-advised fund	None; deduction at fair market value up to 30% of AGI	Yes	Long-term lots; charitable intent	None found
Charitable remainder trust	None in the trust; payouts taxed as received	Yes	Size to justify administration	None found
Direct indexing	Offsets gains with harvested losses	Not by itself	Outside assets to fund the sleeve	None

How we approach a concentrated position

We read the policy and the lockup terms first, then build the lot inventory: acquisition date, basis, holding period and award type for every lot, because the cheapest share to sell is rarely the one the brokerage picks by default. That is the starting point of our equity compensation and concentrated stock work. The plan is usually a written sell rule, often inside a 10b5-1 plan, paired with gifts of the oldest long-term lots where the household gives anyway, and a direct-indexed core that harvests losses against the sales. The tax side follows our sequence for planning capital gains after a liquidity event, without letting tax steer the decision, a trade-off covered in when tax planning distorts the portfolio. Where a household is eligible, past its lockup, and at an employer whose policy allows it, exchange funds, forwards and collars enter the discussion with their four lines attached, coordinated with the household’s CPA through our tax planning process.

Questions worth answering before choosing a strategy

What does my insider trading policy prohibit, for me and for my household, at all times?
Are any of my shares still locked, and when does each release?
What share of net worth is the stock today, and what share do we want in three years?
Which lots are long-term, and which have the highest basis?
Would a 10b5-1 plan help, and does its cooling-off period line up with the dates that matter?
Do we give to charity anyway, and could long-term lots fund those gifts?
Do we meet the accredited investor or qualified purchaser tests, and does it matter given the policy?
What is the tax on the sale we are avoiding, and what is the loss we would accept to avoid it?

What this does not mean

Nothing here recommends buying, selling, holding or hedging shares of any company, and the illustration is arithmetic on assumed numbers, not a forecast. The policies in the first table belong to the companies named, are cited to identify the rules discussed, and may have changed since filing; The Financial Sciences Company is not affiliated with, endorsed by, or sponsored by any of them. Exchange funds, forwards and collars are available only to certain investors, only outside a lockup, and only where the employer’s policy permits. Tax figures are 2026 federal figures; your own return depends on your state, your other income and each lot’s history. Confirm the details with a CPA or tax counsel.

Frequently asked questions

Can I hedge my company stock with a collar while I am still employed?

Often not. Insider trading policies filed by NVIDIA, Apple, Alphabet and Meta prohibit hedging and derivative transactions for covered employees at all times, and several also ban pledging. Shares under an IPO lockup cannot be hedged at all. Read your own policy before talking to a dealer.

Does an exchange fund let me diversify without paying tax?

It defers the tax rather than removing it: your basis carries into the partnership interest, and withdrawing diversified shares within seven years triggers the built-in gain. It requires accredited investor or qualified purchaser status, charges fees for the life of the fund, holds about 20% in real estate, and may be barred by your employer’s policy, as Meta’s is by name.

How does a 10b5-1 plan help with a concentrated position?

It commits you to a selling schedule in advance so trades execute on their own, including in closed windows. Employees who are not directors or officers wait 30 days after adoption before the plan can trade; directors and officers wait the later of 90 days or two business days after the next quarterly results, up to 120 days.

How much tax does selling over several years save?

In the illustration, a single filer with $200,000 of other income and a $1,600,000 long-term gain saves about $51,825 of federal tax by selling over four years instead of one, because $345,500 of gain runs through the 15% band each year. A decline of about 3.5% in the unsold shares would offset that saving.

What is the tax benefit of giving appreciated stock to a donor-advised fund?

For publicly traded stock held more than a year and given to a public charity, the deduction is fair market value, limited to 30% of adjusted gross income with a five-year carryover, and the built-in gain is never taxed. Shares held a year or less are deductible only at basis. From 2026, only total gifts above 0.5% of adjusted gross income count.

Does direct indexing reduce a concentrated position?

Not by itself. It holds the rest of the portfolio as individual index stocks, excluding the employer and often its sector, and harvests losses that offset gains from selling the concentrated shares. It makes staged selling cheaper; the selling still has to happen.

Sources and further reading

Next steps

Keep reading

Equity Compensation · 14 min readRule 10b5-1 Plans for Employees, Not Just Executives

Equity Compensation · 17 min readIPO Lockup Expiration: What to Do Before Release

Equity Compensation · 19 min readESPP: Sell Right Away or Hold? The 2026 Tax Rules

Get the weekly market brief.

Once a week, we send a concise roundup of the most important market stories and what they may mean for financial markets, portfolio decisions, and planning strategy.

The views and opinions expressed here are those of The Financial Sciences Company as of the publish date and are provided for informational and educational purposes only. They are not personalized investment, tax, or legal advice. The Financial Sciences Company, LLC is a registered investment adviser. Registration does not imply a certain level of skill or training. Additional information is available in our Form ADV at adviserinfo.sec.gov.

General educational information, current as of 2026. Figures and rules change. For guidance specific to your situation, speak with a qualified professional.